Multidisciplinary Consensus on the Management of Non-Invasive Respiratory Support in the COVID-19 Patient.

Acute respiratory failure due to COVID-19 pneumonia often requires a comprehensive approach that includes non-pharmacological strategies such as non-invasive support (including positive pressure modes, high flow therapy or awake proning) in addition to oxygen therapy, with the primary goal of avoiding endotracheal intubation. Clinical issues such as determining the optimal time to initiate non-invasive support, choosing the most appropriate modality (based not only on the acute clinical picture but also on comorbidities), establishing criteria for recognition of treatment failure and strategies to follow in this setting (including palliative care), or implementing de-escalation procedures when improvement occurs are of paramount importance in the ongoing management of severe COVID-19 cases. Organizational issues, such as the most appropriate setting for management and monitoring of the severe COVID-19 patient or protective measures to prevent virus spread to healthcare workers in the presence of aerosol-generating procedures, should also be considered. While many early clinical guidelines during the pandemic were based on previous experience with acute respiratory distress syndrome, the landscape has evolved since then. Today, we have a wealth of high-quality studies that support evidence-based recommendations to address these complex issues. This document, the result of a collaborative effort between four leading scientific societies (SEDAR, SEMES, SEMICYUC, SEPAR), draws on the experience of 25 experts in the field to synthesize knowledge to address pertinent clinical questions and refine the approach to patient care in the face of the challenges posed by severe COVID-19 infection.

Failure of Non-Invasive Respiratory Support in Patients with SARS-CoV-2.

INTRODUCTION: The objective of this study is to assess the failure of therapies with HFNO (high-flow nasal oxygen), CPAP, Bilevel, or combined therapy in patients with hypoxemic acute respiratory failure due to SARS-CoV-2 during their hospitalization. METHODS: This was a retrospective and observational study of SARS-CoV-2-positive patients who required non-invasive respiratory support (NIRS) at the Reina Sofía General University Hospital of Murcia between March 2020 and May 2021. RESULTS: Of 7355 patients, 197 (11.8%) were included; 95 of them failed this therapy (48.3%). We found that during hospitalization in the ward, the combined therapy of HFNO and CPAP had an overall lower failure rate and the highest treatment with Bilevel (p = 0.005). In the comparison of failure in therapy without two levels of airway pressure, HFNO, CPAP, and combined therapy of HFNO with CPAP, (35.6% of patients) presented with 24.2% failure, compared to those who had two levels of pressure with Bilevel and combined therapy of HFNO with Bilevel (64.4% of patients), with 75.8% associated failure (OR: 0, 374; CI 95%: 0.203-0.688. p = 0.001). CONCLUSIONS: The use of NIRS during conventional hospitalization is safe and effective in patients with respiratory failure secondary to SARS-CoV-2 infection. The therapeutic strategy of Bilevel increases the probability of failure, with the combined therapy strategy of CPAP and HFNO being the most promising option.

Summary of Recommendations and Key Points of the Consensus of Spanish Scientific Societies (SEPAR, SEMICYUC, SEMES; SECIP, SENEO, SEDAR, SENP) on the Use of Non-Invasive Ventilation and High-Flow Oxygen Therapy with Nasal Cannulas in Adult, Pediatric, and Neonatal Patients With Severe Acute Respiratory Failure.

Non-invasive respiratory support (NIRS) in adult, pediatric, and neonatal patients with acute respiratory failure (ARF) comprises two treatment modalities, non-invasive mechanical ventilation (NIMV) and high-flow nasal cannula (HFNC) therapy. However, experts from different specialties disagree on the benefit of these techniques in different clinical settings. The objective of this consensus was to develop a series of good clinical practice recommendations for the application of non-invasive support in patients with ARF, endorsed by all scientific societies involved in the management of adult and pediatric/neonatal patients with ARF. To this end, the different societies involved were contacted, and they in turn appointed a group of 26 professionals with sufficient experience in the use of these techniques. Three face-to-face meetings were held to agree on recommendations (up to a total of 71) based on a literature review and the latest evidence associated with 3 categories: indications, monitoring and follow-up of NIRS. Finally, the experts from each scientific society involved voted telematically on each of the recommendations. To classify the degree of agreement, an analog classification system was chosen that was easy and intuitive to use and that clearly stated whether the each NIRS intervention should be applied, could be applied, or should not be applied.

Summary of Recommendations and Key Points of the Consensus of Spanish Scientific Societies (SEPAR, SEMICYUC, SEMES; SECIP, SENEO, SEDAR, SENP) on the Use of Non-Invasive Ventilation and High-Flow Oxygen Therapy with Nasal Cannulas in Adult, Pediatric, and Neonatal Patients With Severe Acute Respiratory Failure / Sumario de recomendaciones y puntos clave del Consenso de las Sociedades Científicas Españolas (SEPAR, SEMICYUC, SEMES; SECIP, SENeo, SEDAR, SENP) para la utilización de la ventilación no invasiva y terapia de alto flujo con cánulas nasales en el paciente adulto, pediátrico y neonatal con insuficiencia respiratoria aguda grave

Non-invasive respiratory support (NIRS) in adult, pediatric, and neonatal patients with acute respiratory failure (ARF) comprises two treatment modalities, non-invasive mechanical ventilation (NIMV) and high-flow nasal cannula (HFNC) therapy. However, experts from different specialties disagree on the benefit of these techniques in different clinical settings. The objective of this consensus was to develop a series of good clinical practice recommendations for the application of non-invasive support in patients with ARF, endorsed by all scientific societies involved in the management of adult and pediatric/neonatal patients with ARF.To this end, the different societies involved were contacted, and they in turn appointed a group of 26 professionals with sufficient experience in the use of these techniques. Three face-to-face meetings were held to agree on recommendations (up to a total of 71) based on a literature review and the latest evidence associated with 3 categories: indications, monitoring and follow-up of NIRS. Finally, the experts from each scientific society involved voted telematically on each of the recommendations. To classify the degree of agreement, an analog classification system was chosen that was easy and intuitive to use and that clearly stated whether the each NIRS intervention should be applied, could be applied, or should not be applied. (AU)

El soporte respiratorio no invasivo (SRNI) comprende 2 modalidades de tratamiento, la ventilación mecánica no invasiva (VMNI) y la terapia de alto flujo con cánulas nasales (TAFCN) que se aplican en pacientes adultos, pediátricos y neonatales con insuficiencia respiratoria aguda (IRA). Sin embargo, el grado de acuerdo entre las distintas especialidades sobre el beneficio de estas técnicas en diferentes escenarios clínicos es controvertido. El objetivo del presente consenso fue elaborar una serie de recomendaciones de buena práctica clínica para la aplicación de soporte no invasivo en pacientes con IRA, avaladas por todas las sociedades científicas involucradas en el manejo del paciente adulto y pediátrico/neonatal con IRA.Para ello se contactó con las diferentes sociedades implicadas, quienes designaron a su vez a un grupo de 26 profesionales con suficiente experiencia en su aplicación. Se realizaron 3 reuniones presenciales para consensuar las recomendaciones (hasta un total de 71) fundamentadas en la revisión de la literatura y en la actualización de la evidencia disponible en relación con 3 categorías: indicaciones, monitorización y seguimiento del SRNI. Finalmente, se procedió a votación telemática de cada una de las recomendaciones, por parte de los expertos de cada sociedad científica implicada. Para la clasificación del grado de acuerdo se optó por un sistema analógico de clasificación fácil e intuitivo de usar, y que expresara con claridad si el procedimiento relacionado con el SRNI debía hacerse, podía hacerse o no debía hacerse. (AU)

Factores predictivos de fracaso en el destete de la ventilación mecánica no invasiva en urgencias / Predictors of noninvasive mechanical ventilation weaning failure in the emergency department

OBJETIVOS: Analizar los factores predictivos del fracaso del destete en los pacientes sometidos a ventilación mecánica no invasiva (VMNI) en un servicio de urgencias hospitalario (SUH). MÉTODO: Estudio observacional de cohortes prospectivo con muestreo consecutivo de los pacientes que precisaron VMNI durante la atención en el SUH. Se estableció como variable dependiente el fracaso del destete de la VMNI, definido comola necesidad de reiniciar o instaurar la VMNI durante el mismo ingreso hospitalario tras el primer intento de destete. RESULTADOS: Del total de 675 pacientes elegibles, se incluyeron 360 pacientes (53,4%). Se excluyeron 100 (31,7%),58 (18,4%) y 157 (49,9%) por VMNI domiciliaria, fracaso previo al intento de destete y por realización del intento de destete fuera del SUH, respectivamente. Sesenta y dos casos (17,3%) presentaron con fracaso del destete de la VMNI. Los factores independientes asociados al fracaso del destete fueron la concentración de bicarbonato antes del destete (ORa: 1,06; IC 95%: 1,01-1,12; p = 0,014), la duración VMNI en horas (ORa: 1,10; IC 95%: 1,04-1,16; p < 0,001) yun pH < 7,35 antes del destete (ORa: 2,48; IC: 1,16-5,31; p = 0,019). CONCLUSIÓN: El fracaso del destete de la VMNI en el SUH ocurrió en un 17% de los casos. La duración de la técnica, elvalor del HCO3- y el pH < 7,35 antes del destete fueron factores independientes asociados al fracaso

OBJETIVES: To analyze factors related to the failure of noninvasive mechanical ventilation (NIV) weaning in a hospital emergency department (ED). METHODS: Prospective, observational cohort study with enrolled a sample of consecutive patients who required NIV during ED care. The dependent variable was NIV weaning failure, defined by the need to restart NIV in the ED after a first attempt to withdraw the respirator. RESULTS: Of a total of 675 candidates, we included 360 patients (53.4%). Exclusions were 100 patients (31.7%) who were on NIV at home; 58 (18.4%) in whom NIV initially failed; and 157 (49.9%) in whom weaning was attempted outside the ED. Seventy-two (17.3%) cases of weaning failure in the ED were observed. Factors independently associated with failure were the bicarbonate (HCO3) concentrations before attempted weaning (adjusted odds ratio [aOR], 1.06; 95% CI, 1.01-1.12;P = .014), time on NIV in hours (aOR, 1.10; 95% CI, 1.04-1.16;P < .001), and a pH less than 7.35 before weaning (aOR, 2.48; 95% CI, 1.16-5.31;P = .019). CONCLUSIONS: Weaning failure occurs in 17% of ED patients on NIV. Time on NIV, HCO3 concentration, and a pH less than 7.35 before weaning are independently associated with failure to wean from the respirator

Predictors of noninvasive mechanical ventilation weaning failure in the emergency department. / Factores predictivos de fracaso en el destete de la ventilación mecánica no invasiva en urgencias.

OBJECTIVES: To analyze factors related to the failure of noninvasive mechanical ventilation (NIV) weaning in a hospital emergency department (ED). MATERIAL AND METHODS: Prospective, observational cohort study with enrolled a sample of consecutive patients who required NIV during ED care. The dependent variable was NIV weaning failure, defined by the need to restart NIV in the ED after a first attempt to withdraw the respirator. RESULTS: Of a total of 675 candidates, we included 360 patients (53.4%). Exclusions were 100 patients (31.7%) who were on NIV at home; 58 (18.4%) in whom NIV initially failed; and 157 (49.9%) in whom weaning was attempted outside the ED. Seventy-two (17.3%) cases of weaning failure in the ED were observed. Factors independently associated with failure were the bicarbonate (HCO3) concentrations before attempted weaning (adjusted odds ratio [aOR], 1.06; 95% CI, 1.01-1.12; P = .014), time on NIV in hours (aOR, 1.10; 95% CI, 1.04-1.16; P .001), and a pH less than 7.35 before weaning (aOR, 2.48; 95% CI, 1.16-5.31; P = .019). CONCLUSION: Weaning failure occurs in 17% of ED patients on NIV. Time on NIV, HCO3 concentration, and a pH less than 7.35 before weaning are independently associated with failure to wean from the respirator.

OBJETIVO: Analizar los factores predictivos del fracaso del destete en los pacientes sometidos a ventilación mecánica no invasiva (VMNI) en un servicio de urgencias hospitalario (SUH). METODO: Estudio observacional de cohortes prospectivo con muestreo consecutivo de los pacientes que precisaron VMNI durante la atención en el SUH. Se estableció como variable dependiente el fracaso del destete de la VMNI, definido como la necesidad de reiniciar o instaurar la VMNI durante el mismo ingreso hospitalario tras el primer intento de destete. RESULTADOS: Del total de 675 pacientes elegibles, se incluyeron 360 pacientes (53,4%). Se excluyeron 100 (31,7%), 58 (18,4%) y 157 (49,9%) por VMNI domiciliaria, fracaso previo al intento de destete y por realización del intento de destete fuera del SUH, respectivamente. Sesenta y dos casos (17,3%) presentaron con fracaso del destete de la VMNI. Los factores independientes asociados al fracaso del destete fueron la concentración de bicarbonato antes del destete (ORa: 1,06; IC 95%: 1,01-1,12; p = 0,014), la duración VMNI en horas (ORa: 1,10; IC 95%: 1,04-1,16; p 0,001) y un pH 7,35 antes del destete (ORa: 2,48; IC: 1,16-5,31; p = 0,019). CONCLUSIONES: El fracaso del destete de la VMNI en el SUH ocurrió en un 17% de los casos. La duración de la técnica, el valor del HCO3 ­ y el pH 7,35 antes del destete fueron factores independientes asociados al fracaso.

Soporte respiratorio en el paciente adulto con insuficiencia respiratoria aguda secundaria a COVID-19 en urgencias y emergencias / Emergency ventilatory support for acute adult respiratory distress syndrome secondary to COVID-19

No disponible

[Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection]. / Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-2.

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.

[Clinical Consensus Recommendations Regarding Non-Invasive Respiratory Support in the Adult Patient with Acute Respiratory Failure Secondary to SARS-CoV-2 infection]. / Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-2.

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure.This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials.

Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-2 / Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection

La enfermedad por coronavirus 2019 (COVID-19) es una infección del tracto respiratorio causada por un nuevo coronavirus emergente, que se reconoció por primera vez en Wuhan, China, en diciembre de 2019. Actualmente, la Organización Mundial de la Salud (OMS) ha definido la infección como pandemia y existe una situación de emergencia sanitaria y social para el manejo de esta nueva infección. Mientras que la mayoría de las personas con COVID-19 desarrollan solo una enfermedad leve o no complicada, aproximadamente el 14% desarrolla una enfermedad grave que requiere hospitalización y oxígeno, y el 5% puede requerir ingreso en una Unidad de Cuidados Intensivos (1). En casos severos, COVID-19 puede complicarse por el síndrome de dificultad respiratoria aguda (SDRA), sepsis y shock séptico y fracaso multiorgánico. Este documento de consenso se ha preparado sobre directrices basadas en evidencia desarrolladas por un panel multidisciplinario de profesionales médicos de cuatro sociedades científicas españolas (Sociedad Española de Medicina Intensiva y Unidades Coronarias [SEMICYUC], Sociedad Española de Neumología y Cirugía Torácica [SEPAR], Sociedad Española de Urgencias y Emergencias [SEMES], Sociedad Española de Anestesiología, Reanimación y Terapéutica delDolor [SEDAR]) con experiencia en el manejo clínico de pacientes con COVID-19 y otras infecciones virales, incluido el SARS, así como en sepsis y SDRA. El documento proporciona recomendaciones clínicas para el soporte respiratorio no invasivo (ventilación no invasiva, oxigenoterapia de alto flujo con cánula nasal) en cualquier paciente con presentación sospechada o confirmada de COVID-19 con insuficiencia respiratoria aguda. Esta guía de consenso debe servir como base para una atención optimizada y garantizar la mejor posibilidad de supervivencia, así como permitir una comparación fiable de las futuras intervenciones terapéuticas de investigación que formen parte de futuros estudios observacionales o de ensayos clínicos. Palabras clave: Ventilación mecánica no invasiva, terapia nasal de alto flujo, procedimientos generadores de aerosoles, control de infección. Esta guía de consenso debe servir como base para una atención optimizada y garantizar la mejor posibilidad de supervivencia, así como permitir una comparación fiable de las futuras intervenciones terapéuticas de investigación que formen parte de futuros estudios observacionales o de ensayos clínicos

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus , that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit (1). In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four spanish scientific societies (Spanish Society of Intensive Care Medicine [SEMICYUC], Spanish Society of Pulmonologists [SEPAR], Spanish Society of Emergency [SEMES], Spanish Society of Anesthesiology, Reanimation, and Pain [SEDAR]) with experience in the clinical management of patients with COVID-19 and other viral infections, including SARS, as well as sepsis and ARDS. The document provides clinical recommendations for the noninvasive respiratory support (noninvasive ventilation, high flow oxygen therapy with nasal cannula) in any patient with suspected or confirmed presentation of COVID-19 with acute respiratory failure. This consensus guidance should serve as a foundation for optimized supportive care to ensure the best possible chance for survival and to allow for reliable comparison of investigational therapeutic interventions as part of randomized controlled trials

[Mortality and acute kidney injury in patients with noninvasive ventilation]. / Mortalidad y fracaso renal agudo en pacientes con ventilación no invasiva.

We developed a prospective observational study, obtaining clinical and analytical data of patients admitted to the intensive care unit of the Hospital Reina Sofía, who required noninvasive ventilation, from January 1, 2013 to December 31, 2015. The main objective was to determine the 90-day mortality in these patients and conditions, who required noninvasive ventilation as treatment for acute respiratory failure and who developed acute kidney injury. Acute renal failure was defined as an increase in serum creatinine > 0.3 mg/dl at 48 hours with respect to the baseline. The patients were followed for 90 days. We analyzed 221 patients, 65 (29.4%) presented acute kidney injury and 156 (70.6%) normal renal function. Overall mortality at 90 days was 44 (19.9%). In the group of acute kidneys injury, it was 33 (51.6%), being 11 (7.1%) in patients without acute kidney injury (RR 7.340, 95% CI: 3.974-13.559, p < 0.001). Hospital stay in days was 24.2 ± 24.1 with acute kidney injury vs. 21.5 ± 0.7, p = 0.429; stay in the intensive care unit in days was 10.9 ± 14.4 with acute kidney injury vs. 7.3 ± 9.6, p = 0.357, and days of non-invasive ventilation 3.4 ± 3.0 with acute kidney injury vs. 2.7 ± 1.9, p = 0.569, in those patients not affected by the presence of acute kidney injury. In conclusion, the presence of acute kidney injury is an independent factor of mortality in patients with acute respiratory failure requiring noninvasive ventilation.

Se efectuó un estudio prospectivo observacional, obteniendo datos clínicos y analíticos de pacientes ingresados en la unidad de cuidados intensivos del Hospital Reina Sofía, que precisaron de ventilación mecánica no invasiva. El estudio se llevó a cabo desde el 1 de enero 2013 al 31 de diciembre de 2015. El objetivo principal fue determinar la mortalidad a los 90 días en pacientes ingresados con estas características en dicho periodo. Se definió como fracaso renal agudo al incremento de creatinina sérica > 0.3 mg/dl a las 48 horas con respecto al basal. Los pacientes fueron seguidos durante 90 días. Se analizaron 221 pacientes, 65 (29.4%) presentaron fracaso renal agudo y 156 (70.6%) función renal normal. La mortalidad global a los 90 días fue de 44 (19.9%); en el grupo del fracaso renal agudo fue de 33 (51.6%), y de 11 (7.1%) en los pacientes sin fracaso renal agudo (RR 7.340; IC 95%: 3.974-13.559. p < 0.001). La estancia hospitalaria fue de 24.2 ± 24.1 días en aquellos con fracaso renal agudo vs. 21.5 ± 20.7 días en el segundo grupo; p = 0.429), la estancia en la unidad de cuidados intensivos: 10.9 ± 14.4 con fracaso renal agudo vs. 7.3 ± 9.6; p = 0.357, sin dicha condición, y los días de ventilación mecánica no invasiva: 3.4 ± 3.0 con fracaso renal agudo vs. 2.7 ± 1.9; p = 0.569, en los que no se vieron afectados por la presencia del fracaso renal agudo. Como conclusión, la presencia de fracaso renal agudo es un factor independiente de mortalidad en los pacientes que presentan insuficiencia respiratoria aguda con necesidad de ventilación mecánica no invasiva.

Mortalidad y fracaso renal agudo en pacientes con ventilación no invasiva / Mortality and acute kidney injury in patients with noninvasive ventilation

Se efectuó un estudio prospectivo observacional, obteniendo datos clínicos y analíticos de pacientes ingresados en la unidad de cuidados intensivos del Hospital Reina Sofía, que precisaron de ventilación mecánica no invasiva. El estudio se llevó a cabo desde el 1 de enero 2013 al 31 de diciembre de 2015. El objetivo principal fue determinar la mortalidad a los 90 días en pacientes ingresados con estas características en dicho periodo. Se definió como fracaso renal agudo al incremento de creatinina sérica > 0.3 mg/dl a las 48 horas con respecto al basal. Los pacientes fueron seguidos durante 90 días. Se analizaron 221 pacientes, 65 (29.4%) presentaron fracaso renal agudo y 156 (70.6%) función renal normal. La mortalidad global a los 90 días fue de 44 (19.9%); en el grupo del fracaso renal agudo fue de 33 (51.6%), y de 11 (7.1%) en los pacientes sin fracaso renal agudo (RR 7.340; IC 95%: 3.974-13.559. p < 0.001). La estancia hospitalaria fue de 24.2 ± 24.1 días en aquellos con fracaso renal agudo vs. 21.5 ± 20.7 días en el segundo grupo; p = 0.429), la estancia en la unidad de cuidados intensivos: 10.9 ± 14.4 con fracaso renal agudo vs. 7.3 ± 9.6; p = 0.357, sin dicha condición, y los días de ventilación mecánica no invasiva: 3.4 ± 3.0 con fracaso renal agudo vs. 2.7 ± 1.9; p = 0.569, en los que no se vieron afectados por la presencia del fracaso renal agudo. Como conclusión, la presencia de fracaso renal agudo es un factor independiente de mortalidad en los pacientes que presentan insuficiencia respiratoria aguda con necesidad de ventilación mecánica no invasiva.

We developed a prospective observational study, obtaining clinical and analytical data of patients admitted to the intensive care unit of the Hospital Reina Sofía, who required noninvasive ventilation, from January 1, 2013 to December 31, 2015. The main objective was to determine the 90-day mortality in these patients and conditions, who required noninvasive ventilation as treatment for acute respiratory failure and who developed acute kidney injury. Acute renal failure was defined as an increase in serum creatinine > 0.3 mg/dl at 48 hours with respect to the baseline. The patients were followed for 90 days. We analyzed 221 patients, 65 (29.4%) presented acute kidney injury and 156 (70.6%) normal renal function. Overall mortality at 90 days was 44 (19.9%). In the group of acute kidneys injury, it was 33 (51.6%), being 11 (7.1%) in patients without acute kidney injury (RR 7.340, 95% CI: 3.974-13.559, p < 0.001). Hospital stay in days was 24.2 ± 24.1 with acute kidney injury vs. 21.5 ± 0.7, p = 0.429; stay in the intensive care unit in days was 10.9 ± 14.4 with acute kidney injury vs. 7.3 ± 9.6, p = 0.357, and days of non-invasive ventilation 3.4 ± 3.0 with acute kidney injury vs. 2.7 ± 1.9, p = 0.569, in those patients not affected by the presence of acute kidney injury. In conclusion, the presence of acute kidney injury is an independent factor of mortality in patients with acute respiratory failure requiring noninvasive ventilation.

[Nomogram to predict a poor outcome in emergency patients with sepsis and at low risk of organ damage according to Sepsis-related Organ Failure Assessment (SOFA)]. / Nomograma para predecir mal pronóstico en pacientes procedentes de urgencias con sepsis y bajo riesgo de daño orgánico evaluado mediante SOFA.

OBJECTIVES: To develop a nomograph to predict a poor outcome (death during hospitalization or a hospital stay longer than 15 days) in emergency patients with sepsis and at low risk of organ damage according to Sepsis-related Organ Failure Assessment (SOFA). MATERIAL AND METHODS: Prospective, observational study carried out in a single universitary hospital. All patients admitted from the emergency department with sepsis and SOFA scores of 6 or lower were enrolled. We used bivariate logistic regression analysis to develop a predictive nomogram. RESULTS: A total of 174 patients were included. Seventeen patients (9.8%) died during hospitalization and the average hospital stay was greater than 15 days in 29 (16.7%) patient. The outcome was poor in a total of 42 patients (24.1%);. Independent variables that were significantly associated with a poor outcome were SOFA score (odds ratio [OR], 1.3; 95% CI, 1.06-1.71; P<.05), C-reactive protein (CRP) concentration (OR, 1.04; 95% CI, 1.0-1.09; P<.05), N-terminal fragment of brain natriuretic peptide (NT-proBNP) concentration over 1330 ng/mL (OR, 2.64; 95% CI, 1.17-6.22; P<.05), and septic shock (OR, 8.3; 95% CI, 1.16-166.5; P<.05). For a SOFA score of 2 or more the crude OR was 4.44 (95%, CI, 1.91-10.34) and the OR adjusted for other variables was 3.08 (95% CI, 1.24-7.69). CONCLUSION: A high percentage of patients predicted to be at low risk of organ failure had poor outcomes, associated with SOFA score, the presence of septic shock, CRP concentration, and elevated NT-proBNP concentration. The SOFA score by itself is an inadequate prognostic tool in patients at low risk of organ damage. Other clinical and analytical variables are required to complement the SOFA score.

OBJETIVO: Elaborar un nomograma que permita predecir el mal pronóstico (mortalidad durante el ingreso o estancia media > 15 días) en pacientes procedentes de urgencias con sepsis y baja probabilidad de daño orgánico evaluado por SOFA (Sepsis-related Organ Failure Assessment). METODO: Estudio observacional prospectivo realizado en un único hospital. Se incluyeron de forma consecutiva pacientes del servicio de urgencias con sepsis y SOFA igual o inferior a 6 puntos. Se realizó un análisis de regresión logística binaria y se elaboró un nomograma predictivo. RESULTADOS: Se incluyeron 174 pacientes. Diecisiete (9,8%) pacientes fallecieron durante la hospitalización y 29 (16,7%) tuvieron una estancia media prolongada. En total, 42 (24,1%) pacientes tuvieron mal pronóstico. Las variables independientes de mal pronóstico fueron: la puntuación SOFA (OR 1,3; IC 95% 1,06-1,71; p < 0,05), las concentraciones de proteína C reactiva (PCR) (OR 1,04; IC 95% 1-1,09; p < 0,05), NT-proBNP > 1.330 ng/ml (OR 2,64; IC 95% 1,17-6,22; p < 0,05) y la presencia de shock séptico (OR 8,3; IC 95% 1,16-166,5; p < 0,05). Si tenemos en cuenta el índice SOFA >= 2, la OR cruda fue 4,44 (IC 95% 1,91-10,34) y ajustada por el resto de variables fue de 3,08 (IC 95%, 1,24-7,69). CONCLUSIONES: Una elevada proporción de pacientes con baja probabilidad de tener daño orgánico tuvieron mal pronóstico en relación con la puntuación en la escala SOFA, la presencia de shock séptico, concentraciones de PCR y NTproBNP. La utilización de la escala pronóstica SOFA en pacientes con bajo riesgo es insuficiente para predecir el pronóstico en estos pacientes y se hace necesario complementarla con otras variables clínicas y analíticas.

Nomograma para predecir mal pronóstico en pacientes procedentes de urgencias con sepsis y bajo riesgo de daño orgánico evaluado mediante SOFA / Nomogram to predict a poor outcome in emergency patients with sepsis and at low risk of organ damage according to Sepsis-related Organ Failure Assessment (SOFA)

Objetivo: Elaborar un nomograma que permita predecir el mal pronóstico (mortalidad durante el ingreso o estancia media > 15 días) en pacientes procedentes de urgencias con sepsis y baja probabilidad de daño orgánico evaluado por SOFA (Sepsis-related Organ Failure Assessment). Método: Estudio observacional prospectivo realizado en un único hospital. Se incluyeron de forma consecutiva pacientes del servicio de urgencias con sepsis y SOFA igual o inferior a 6 puntos. Se realizó un análisis de regresión logística binaria y se elaboró un nomograma predictivo. Resultados: Se incluyeron 174 pacientes. Diecisiete (9,8%) pacientes fallecieron durante la hospitalización y 29 (16,7%) tuvieron una estancia media prolongada. En total, 42 (24,1%) pacientes tuvieron mal pronóstico. Las variables independientes de mal pronóstico fueron: la puntuación SOFA (OR 1,3; IC 95% 1,06-1,71; p < 0,05), las concentraciones de proteína C reactiva (PCR) (OR 1,04; IC 95% 1-1,09; p < 0,05), NT-proBNP > 1.330 ng/ml (OR 2,64; IC 95% 1,17-6,22; p < 0,05) y la presencia de shock séptico (OR 8,3; IC 95% 1,16-166,5; p < 0,05). Si tenemos en cuenta el índice SOFA _ 2, la OR cruda fue 4,44 (IC 95% 1,91-10,34) y ajustada por el resto de variables fue de 3,08 (IC 95%, 1,24-7,69). Conclusiones: Una elevada proporción de pacientes con baja probabilidad de tener daño orgánico tuvieron mal pronóstico en relación con la puntuación en la escala SOFA, la presencia de shock séptico, concentraciones de PCR y NTproBNP. La utilización de la escala pronóstica SOFA en pacientes con bajo riesgo es insuficiente para predecir el pronóstico en estos pacientes y se hace necesario complementarla con otras variables clínicas y analíticas (AU)

Objective: To develop a nomograph to predict a poor outcome (death during hospitalization or a hospital stay longer than 15 days) in emergency patients with sepsis and at low risk of organ damage according to Sepsis-related Organ Failure Assessment (SOFA). Methods: Prospective, observational study carried out in a single universitary hospital. All patients admitted from the emergency department with sepsis and SOFA scores of 6 or lower were enrolled. We used bivariate logistic regression analysis to develop a predictive nomogram. Results: A total of 174 patients were included. Seventeen patients (9.8%) died during hospitalization and the average hospital stay was greater than 15 days in 29 (16.7%) patient. The outcome was poor in a total of 42 patients (24.1%);. Independent variables that were significantly associated with a poor outcome were SOFA score (odds ratio [OR], 1.3; 95% CI, 1.06-1.71; P<.05), C-reactive protein (CRP) concentration (OR, 1.04; 95% CI, 1.0-1.09; P<.05), N-terminal fragment of brain natriuretic peptide (NT-proBNP) concentration over 1330 ng/mL (OR, 2.64; 95% CI, 1.17-6.22; P<.05), and septic shock (OR, 8.3; 95% CI, 1.16-166.5; P<.05). For a SOFA score of 2 or more the crude OR was 4.44 (95%, CI, 1.91-10.34) and the OR adjusted for other variables was 3.08 (95% CI, 1.24-7.69). Conclusions: A high percentage of patients predicted to be at low risk of organ failure had poor outcomes, associated with SOFA score, the presence of septic shock, CRP concentration, and elevated NT-proBNP concentration. The SOFA score by itself is an inadequate prognostic tool in patients at low risk of organ damage. Other clinical and analytical variables are required to complement the SOFA score (AU)

Relación entre la movilidad diafragmática medida por ecografía y la presión parcial arterial de CO2 en pacientes con insuficiencia respiratoria aguda hipercápnica tras el inicio de la ventilación mecánica no invasiva en urgencias / Relation between ultrasound-measured diaphragm movement and partial pressure of carbon dioxide in blood from patients with acute hypercapnic respiratory failure after the start of noninvasive ventilation in an emergency department

Objetivo: Correlacionar la variación de la movilidad diafragmática (MD), medida a través de ecografía, con el cambio en la presión parcial arterial de CO2 de (pCO2) tras el inicio de la ventilación mecánica no invasiva (VMNI). Método: Estudio descriptivo de una serie de casos prospectivo que incluyó por oportunidad a los pacientes de 18 o más años con insuficiencia respiratoria hipercápnica en los que se inició la VMNI en urgencias. Se recogieron variables clínicas, gasométricas y mediciones ecográficas de la MD directa (MDD) y MD portal (MDP). Resultados: Se incluyeron 21 pacientes, con una edad media de 83 (DE 13) años, de ellos 11 mujeres (52,4%). Los valores de MDD y pCO2 fueron: 1) basal: MDD 13,9 (DE 7,7) mm y pCO2 71,7 (DE: 11,4) mmHg; 2) 15 minutos: MDD 17,1 (DE 9,1) mm; 3) 1 hora: MDD 22,4 (DE 10,4) y pCO2 63,4 (DE: 16,0) mmHg; 4) 3 horas: MDD 26,6 (DE: 19,5) mm y pCO2 61,8 (DE :13,0) mmHg. Hubo correlación estadísticamente significativa entre la diferencia a los 15 minutos y basal de MDD y el descenso a la hora de pCO2 (r = -0,489; p = 0,035). Conclusión: El aumento de la MDD a los 15 minutos del inicio de la VMNI se relaciona con una disminución de la pCO2 a la hora en los pacientes con insuficiencia respiratoria hipercápnica (AU)

Objective: To evaluate the correlation between variations in ultrasound-measured diaphragm movement and changes in the arterial partial pressure of carbon dioxide (PCO2) after the start of noninvasive ventilation (NIV). Methods: Descriptive study of a prospective case series comprised of nonconsecutive patients aged 18 years or older with hypercapnic respiratory failure who were placed on NIV in an emergency department. We recorded clinical data, blood gas measurements, and ultrasound measurements of diaphragm movement. Results: Twenty-one patients with a mean (SD) age of 83 (13) years were studied; 11 (52.4%) were women. The mean (SD) range of diaphragm movement and PCO2 values at 4 moments were as follows: 1) at baseline: diaphragm movement, 13.90 (7.7) mm and PCO2, 71.75 (11.4) mm Hg; 2) after 15 minutes on NIV: diaphragm movement, 17.10 (9.1) mm; 3) at 1 hour: diaphragm movement, 22.40 (10.4) mm and PCO2, 63.45 (16.0) mm Hg; and 4) at 3 hours: diaphragm movement, 26.60 (19.5) mm and PCO2, 61.85 (13.0) mm Hg. We detected a statistically significant correlation between the difference in range of diaphragm movement at baseline and at 15 minutes and the decrease in PCO2 after 1 hour of NIV (r=-0.489, P=.035). Conclusion: In patients with hypercapnic respiratory failure, the increase in range of diaphragm movement 15 minutes after starting NIV is associated with a decrease in PCO2 after 1 hour (AU)

[Relation between ultrasound-measured diaphragm movement and partial pressure of carbon dioxide in blood from patients with acute hypercapnic respiratory failure after the start of noninvasive ventilation in an emergency department]. / Relación entre la movilidad diafragmática medida por ecografía y la presión parcial arterial de CO2 en pacientes con insuficiencia respiratoria aguda hipercápnica tras el inicio de la ventilación mecánica no invasiva en urgencias.

OBJECTIVES: To evaluate the correlation between variations in ultrasound-measured diaphragm movement and changes in the arterial partial pressure of carbon dioxide (PCO2) after the start of noninvasive ventilation (NIV). MATERIAL AND METHODS: RDescriptive study of a prospective case series comprised of nonconsecutive patients aged 18 years or older with hypercapnic respiratory failure who were placed on NIV in an emergency department. We recorded clinical data, blood gas measurements, and ultrasound measurements of diaphragm movement. RESULTS: Twenty-one patients with a mean (SD) age of 83 (13) years were studied; 11 (52.4%) were women. The mean (SD) range of diaphragm movement and PCO2 values at 4 moments were as follows: 1) at baseline: diaphragm movement, 13.90 (7.7) mm and PCO2, 71.75 (11.4) mm Hg; 2) after 15 minutes on NIV: diaphragm movement, 17.10 (9.1) mm; 3) at 1 hour: diaphragm movement, 22.40 (10.4) mm and PCO2, 63.45 (16.0) mm Hg; and 4) at 3 hours: diaphragm movement, 26.60 (19.5) mm and PCO2, 61.85 (13.0) mm Hg. We detected a statistically significant correlation between the difference in range of diaphragm movement at baseline and at 15 minutes and the decrease in PCO2 after 1 hour of NIV (r=-0.489, P=.035). CONCLUSION: In patients with hypercapnic respiratory failure, the increase in range of diaphragm movement 15 minutes after starting NIV is associated with a decrease in PCO2 after 1 hour.

OBJETIVO: Correlacionar la variación de la movilidad diafragmática (MD), medida a través de ecografía, con el cambio en la presión parcial arterial de CO2 de (pCO2) tras el inicio de la ventilación mecánica no invasiva (VMNI). METODO: Estudio descriptivo de una serie de casos prospectivo que incluyó por oportunidad a los pacientes de 18 o más años con insuficiencia respiratoria hipercápnica en los que se inició la VMNI en urgencias. Se recogieron variables clínicas, gasométricas y mediciones ecográficas de la MD directa (MDD) y MD portal (MDP). RESULTADOS: Se incluyeron 21 pacientes, con una edad media de 83 (DE 13) años, de ellos 11 mujeres (52,4%). Los valores de MDD y pCO2 fueron: 1) basal: MDD 13,9 (DE 7,7) mm y pCO2 71,7 (DE: 11,4) mmHg; 2) 15 minutos: MDD 17,1 (DE 9,1) mm; 3) 1 hora: MDD 22,4 (DE 10,4) y pCO2 63,4 (DE: 16,0) mmHg; 4) 3 horas: MDD 26,6 (DE: 19,5) mm y pCO2 61,8 (DE :13,0) mmHg. Hubo correlación estadísticamente significativa entre la diferencia a los 15 minutos y basal de MDD y el descenso a la hora de pCO2 (r = ­0,489; p = 0,035). CONCLUSIONES: El aumento de la MDD a los 15 minutos del inicio de la VMNI se relaciona con una disminución de la pCO2 a la hora en los pacientes con insuficiencia respiratoria hipercápnica.

Yatrogenia tras la técnica de punción lumbar. Estudio de prevalencia de cefalea y factores asociados / Iatrogenic after spinal puncture technique. Prevalence study of headache and associated factors

Objetivo. Establecer la prevalencia existente de cefalea tras practicar una punción lumbar transdural y los factores de riesgo. Pacientes y métodos. Estudio observacional prospectivo de cohortes. Se reclutaron pacientes del Servicio de Urgencias, del Servicio de Neurología y del Hospital de Día. Se recogió la experiencia del facultativo, el número de punciones, la variación de plano, la postura del paciente, el anestésico local, el calibre y bisel de la aguja, los grados de inclinación, la cantidad de líquido, la sobrecarga de fluido terapia y la indicación o no de reposo tras la punción. Tras 48 horas, se estableció la aparición o no de cefalea. Resultados. Muestra de 59 pacientes, 31 (52,5%) de ellos hombres. Edad media: 47 años; 32 (54,2%) procedentes de Urgencias, 18 (30,5%) de Neurología y 9 (15,3%) del Hospital de Día. Hubo 41 (69,5%) en decúbito lateral y 7 (11,9%) en sedestación. Todos con agujas biseladas, 21 (35,6%) del calibre 20 y 38 (64,4%) del calibre 22. Sin reposo estuvieron 8 (13,56%) pacientes y 18 (33,3%) sin sobrecarga de fluidos. Veintitrés (38,98%) con cefalea pos punción lumbar, 12 (52,2%) mujeres, con una edad media de 38,3 ± 16,4 años. La mediana de intensidad de la cefalea fue de 2,6. El tiempo medio de aparición fue de siete horas. Sin diferencias para ninguno de los factores estudiados, salvo la tendencia observada de mayor incidencia de cefalea a menor edad. Conclusiones. La cefalea pospuncion lumbar en nuestra serie es elevada, sin diferencias según el servicio donde se practica o la experiencia. Tampoco influye la cantidad de líquido extraído, la posición del paciente, la indicación de reposo o la sobrecarga de fluidos (AU)

Aim. To determine the prevalence of headache following a transdural lumbar puncture and the risk factors involved. Patients and methods. The method used was a prospective observation-based cohort study. Patients were recruited from the A&E Department, Neurology Service and Day Care Clinic. The following data were collected: physician’s experience, number of punctures, variations in the plane, patient’s posture, local anaesthetic, needle calibre and bevel, degrees of inclination, amount of liquid, fluid overload and whether or not rest is indicated after the puncture. After 48 hours, the appearance of headache (or not) was determined. Results. The sample consisted of 59 patients, 31 (52.5%) of whom were males. Mean age: 47 years; 32 patients (54.2%) came from A&E, 18 (30.5%) from Neurology and 9 (15.3%) from the Day Care Clinic. Forty-one (69.5%) received the lumbar puncture in a lateral decubitus position and 7 (11.9%) in a seated position. All the needles were bevelled, 21 (35.6%) with a calibre of 20 and 3 (64.4%) of calibre 22. Eight patients (13.56%) were without repose and 18 (33.3%) had no fluid overload. Twenty-three (38.98%) had post-lumbar-puncture headache, 12 (52.2%) of them females, with a mean age of 38.3 ± 16.4 years. The median of the headache intensity was 2.6. The mean time of appearance was seven hours. There were no differences for any of the factors studied, except the observed tendency towards a higher incidence of headache at younger ages. Conclusions. Rates of post-lumbar-puncture headache in our series are high, and no differences were found in terms of the service where it was performed or experience. No influence was observed due to the amount of liquid extracted, the patient’s position, the indication of repose or fluid overload (AU)

[Iatrogenic after spinal puncture technique. Prevalence study of headache and associated factors]. / Yatrogenia tras la tecnica de puncion lumbar. Estudio de prevalencia de cefalea y factores asociados.

AIM: To determine the prevalence of headache following a transdural lumbar puncture and the risk factors involved. PATIENTS AND METHODS: The method used was a prospective observation-based cohort study. Patients were recruited from the A and E Department, Neurology Service and Day Care Clinic. The following data were collected: physician's experience, number of punctures, variations in the plane, patient's posture, local anaesthetic, needle calibre and bevel, degrees of inclination, amount of liquid, fluid overload and whether or not rest is indicated after the puncture. After 48 hours, the appearance of headache (or not) was determined. RESULTS: The sample consisted of 59 patients, 31 (52.5%) of whom were males. Mean age: 47 years; 32 patients (54.2%) came from A and E, 18 (30.5%) from Neurology and 9 (15.3%) from the Day Care Clinic. Forty-one (69.5%) received the lumbar puncture in a lateral decubitus position and 7 (11.9%) in a seated position. All the needles were bevelled, 21 (35.6%) with a calibre of 20 and 38 (64.4%) of calibre 22. Eight patients (13.56%) were without repose and 18 (33.3%) had no fluid overload. Twenty-three (38.98%) had post-lumbar-puncture headache, 12 (52.2%) of them females, with a mean age of 38.3 ± 16.4 years. The median of the headache intensity was 2.6. The mean time of appearance was seven hours. There were no differences for any of the factors studied, except the observed tendency towards a higher incidence of headache at younger ages. CONCLUSIONS: Rates of post-lumbar-puncture headache in our series are high, and no differences were found in terms of the service where it was performed or experience. No influence was observed due to the amount of liquid extracted, the patient's position, the indication of repose or fluid overload.

TITLE: Yatrogenia tras la tecnica de puncion lumbar. Estudio de prevalencia de cefalea y factores asociados.Objetivo. Establecer la prevalencia existente de cefalea tras practicar una puncion lumbar transdural y los factores de riesgo. Pacientes y metodos. Estudio observacional prospectivo de cohortes. Se reclutaron pacientes del Servicio de Urgencias, del Servicio de Neurologia y del Hospital de Dia. Se recogio la experiencia del facultativo, el numero de punciones, la variacion de plano, la postura del paciente, el anestesico local, el calibre y bisel de la aguja, los grados de inclinacion, la cantidad de liquido, la sobrecarga de fluidoterapia y la indicacion o no de reposo tras la puncion. Tras 48 horas, se establecio la aparicion o no de cefalea. Resultados. Muestra de 59 pacientes, 31 (52,5%) de ellos hombres. Edad media: 47 años; 32 (54,2%) procedentes de Urgencias, 18 (30,5%) de Neurologia y 9 (15,3%) del Hospital de Dia. Hubo 41 (69,5%) en decubito lateral y 7 (11,9%) en sedestacion. Todos con agujas biseladas, 21 (35,6%) del calibre 20 y 38 (64,4%) del calibre 22. Sin reposo estuvieron 8 (13,56%) pacientes y 18 (33,3%) sin sobrecarga de fluidos. Veintitres (38,98%) con cefalea pospuncion lumbar, 12 (52,2%) mujeres, con una edad media de 38,3 ± 16,4 años. La mediana de intensidad de la cefalea fue de 2,6. El tiempo medio de aparicion fue de siete horas. Sin diferencias para ninguno de los factores estudiados, salvo la tendencia observada de mayor incidencia de cefalea a menor edad. Conclusiones. La cefalea pospuncion lumbar en nuestra serie es elevada, sin diferencias segun el servicio donde se practica o la experiencia. Tampoco influye la cantidad de liquido extraido, la posicion del paciente, la indicacion de reposo o la sobrecarga de fluidos.

Mortalidad de los pacientes con fracaso respiratorio agudo en tratamiento crónico con benzodiacepinas / Mortality in patients with acute respiratory failure on chronic treatment with benzodiazepines

Las benzodiacepinas (BDZ) se encuentran entre los fármacos más usados por la población; entre sus contraindicaciones encontramos la insuficiencia respiratoria severa y la apnea del sueño. El objetivo principal fue establecer la relación entre el consumo crónico de BDZ y la mortalidad intrahospitalaria y a los 30 d. Se estudió una cohorte retrospectiva de 243 pacientes ingresados a lo largo del año 2011 a través del Servicio de Urgencias del Hospital General Universitario Reina Sofía de Murcia a los que se les seleccionó por haber sido tratados con ventilación mecánica no invasiva (VMNI) durante su ingreso. El método empleado fue la revisión de historias clínicas obtenidas del archivo mediante su búsqueda por el código correspondiente al proceso de VMNI. La mortalidad global fue del 20,6%. En los pacientes con consumo crónico de BZD fue del 22,45% por un 19,4% de los pacientes que no las tomaban (p = 0,608). No hemos podido establecer, por tanto, una asociación significativa entre la mortalidad global y el consumo crónico de BZD. Por otra parte, hemos relacionado el incremento de la mortalidad en los pacientes tratados con VMNI por insuficiencia respiratoria aguda con indicadores como la edad > 75 años, el bicarbonato en sangre < 22 mmol/L, el ácido láctico > 2 mmol/L, la creatinina sérica > 1,5 mg/dl y el diagnóstico de sepsis (AU)

The benzodiazepines (BZD) are among the drugs most used by the population. Its contraindications include severe respiratory failure and sleep apnoea. The main objective of this work was to establish the relationship between the chronic use of benzodiazepines and hospital mortality and up to 30 days after admission. This study was carried out on a retrospective cohort of 243 patients admitted via emergency room into «Reina Sofia» University General Hospital in Murcia during the year 2011, and were selected for having been treated with non-invasive mechanical ventilation (NIV) during their admission. The method used was a review of clinical histories by searching for the code corresponding to the NIV process. Overall mortality was 20.6%. In patients with chronic consumption of BZD it was 22.45% and 19.4% in patients who did not use these drugs (P = .608).We were unable to establish a significant relationship between chronic use of benzodiazepines and overall mortality figures. On the other hand, we have linked the increased mortality in patients treated with NIV for acute respiratory failure with other indicators such as, age above 75 years old, blood bicarbonate below 22 mmol/L; lactic acid higher than 2 mmol/L; serum creatinine above 1.5 mg/dL, and sepsis (AU)